Epidiolex (cannabidiol oral solution) — Medica
Treatment-refractory seizures/epilepsy in specific rare conditions (CDKL5 deficiency disorder, Dup15q, Aicardi, or Doose syndromes; febrile infection-related epilepsy syndromes; focal epilepsy; Sturge-Weber syndrome; lissencephaly; cortical malformation/dysplasia; epilepsy with myoclonic absences)
Initial criteria
- age ≥ 1 year
- Patient has tried or is concomitantly receiving at least two other antiseizure medications
Approval duration
1 year